140 related articles for article (PubMed ID: 21840715)
1. I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles.
Anilkumar GN; Lesburg CA; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Vaccaro H; Wang L; Bennett F; Chen KX; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Butkiewicz N; Feld B; Ferrari E; He Z; Jiang CK; Palermo RE; McMonagle P; Huang HC; Shih NY; Njoroge G; Kozlowski JA
Bioorg Med Chem Lett; 2011 Sep; 21(18):5336-41. PubMed ID: 21840715
[TBL] [Abstract][Full Text] [Related]
2. II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides.
Anilkumar GN; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Wang L; Bennett F; Chen KX; Lesburg CA; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Ferrari E; Jiang CK; Huang HC; Shih NY; George Njoroge F; Kozlowski JA
Bioorg Med Chem Lett; 2012 Jan; 22(1):713-7. PubMed ID: 22104146
[TBL] [Abstract][Full Text] [Related]
3. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.
Ding M; He F; Hudyma TW; Zheng X; Poss MA; Kadow JF; Beno BR; Rigat KL; Wang YK; Fridell RA; Lemm JA; Qiu D; Liu M; Voss S; Pelosi LA; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2012 Apr; 22(8):2866-71. PubMed ID: 22424979
[TBL] [Abstract][Full Text] [Related]
5. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.
Zheng X; Hudyma TW; Martin SW; Bergstrom C; Ding M; He F; Romine J; Poss MA; Kadow JF; Chang CH; Wan J; Witmer MR; Morin P; Camac DM; Sheriff S; Beno BR; Rigat KL; Wang YK; Fridell R; Lemm J; Qiu D; Liu M; Voss S; Pelosi L; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2011 May; 21(10):2925-9. PubMed ID: 21486696
[TBL] [Abstract][Full Text] [Related]
7. 2-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid with inbuilt β-N-hydroxy-γ-keto-acid pharmacophore as HCV NS5B polymerase inhibitors.
Deore RR; Chen GS; Chen CS; Chang PT; Chuang MH; Chern TR; Wang HC; Chern JW
Curr Med Chem; 2012; 19(4):613-24. PubMed ID: 22204334
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase.
Chen KX; Vibulbhan B; Yang W; Sannigrahi M; Velazquez F; Chan TY; Venkatraman S; Anilkumar GN; Zeng Q; Bennet F; Jiang Y; Lesburg CA; Duca J; Pinto P; Gavalas S; Huang Y; Wu W; Selyutin O; Agrawal S; Feld B; Huang HC; Li C; Cheng KC; Shih NY; Kozlowski JA; Rosenblum SB; Njoroge FG
J Med Chem; 2012 Jan; 55(2):754-65. PubMed ID: 22148957
[TBL] [Abstract][Full Text] [Related]
9. Discovery of an irreversible HCV NS5B polymerase inhibitor.
Zeng Q; Nair AG; Rosenblum SB; Huang HC; Lesburg CA; Jiang Y; Selyutin O; Chan TY; Bennett F; Chen KX; Venkatraman S; Sannigrahi M; Velazquez F; Duca JS; Gavalas S; Huang Y; Pu H; Wang L; Pinto P; Vibulbhan B; Agrawal S; Ferrari E; Jiang CK; Li C; Hesk D; Gesell J; Sorota S; Shih NY; Njoroge FG; Kozlowski JA
Bioorg Med Chem Lett; 2013 Dec; 23(24):6585-7. PubMed ID: 24252545
[TBL] [Abstract][Full Text] [Related]
10. Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.
Parcella K; Nickel A; Beno BR; Sheriff S; Wan C; Wang YK; Roberts SB; Meanwell NA; Kadow JF
Bioorg Med Chem Lett; 2017 Jan; 27(2):295-298. PubMed ID: 27908764
[TBL] [Abstract][Full Text] [Related]
11. Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
Gopalsamy A; Lim K; Ciszewski G; Park K; Ellingboe JW; Bloom J; Insaf S; Upeslacis J; Mansour TS; Krishnamurthy G; Damarla M; Pyatski Y; Ho D; Howe AY; Orlowski M; Feld B; O'Connell J
J Med Chem; 2004 Dec; 47(26):6603-8. PubMed ID: 15588095
[TBL] [Abstract][Full Text] [Related]
12. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
[TBL] [Abstract][Full Text] [Related]
14. Finger-loop inhibitors of the HCV NS5b polymerase. Part 1: Discovery and optimization of novel 1,6- and 2,6-macrocyclic indole series.
McGowan D; Vendeville S; Lin TI; Tahri A; Hu L; Cummings MD; Amssoms K; Berke JM; Canard M; Cleiren E; Dehertogh P; Last S; Fransen E; Van Der Helm E; Van den Steen I; Vijgen L; Rouan MC; Fanning G; Nyanguile O; Van Emelen K; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2012 Jul; 22(13):4431-6. PubMed ID: 22542193
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors.
Golub AG; Gurukumar KR; Basu A; Bdzhola VG; Bilokin Y; Yarmoluk SM; Lee JC; Talele TT; Nichols DB; Kaushik-Basu N
Eur J Med Chem; 2012 Dec; 58():258-64. PubMed ID: 23127989
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold.
Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L
Bioorg Med Chem Lett; 2018 Mar; 28(5):963-968. PubMed ID: 29422387
[TBL] [Abstract][Full Text] [Related]
17. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.
Chan L; Das SK; Reddy TJ; Poisson C; Proulx M; Pereira O; Courchesne M; Roy C; Wang W; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Labrecque D; Bethell R; Hamel M; Courtemanche-Asselin P; L'Heureux L; David M; Nicolas O; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):793-6. PubMed ID: 14741291
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new 4,5-dihydrofuranoindoles and their evaluation as HCV NS5B polymerase inhibitors.
Velázquez F; Venkatraman S; Lesburg CA; Duca J; Rosenblum SB; Kozlowski JA; Njoroge FG
Org Lett; 2012 Jan; 14(2):556-9. PubMed ID: 22220815
[TBL] [Abstract][Full Text] [Related]
19. From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons.
Beaulieu PL; Gillard J; Jolicoeur E; Duan J; Garneau M; Kukolj G; Poupart MA
Bioorg Med Chem Lett; 2011 Jun; 21(12):3658-63. PubMed ID: 21550240
[TBL] [Abstract][Full Text] [Related]
20. Discovery of HCV NS5B thumb site I inhibitors: core-refining from benzimidazole to indole scaffold.
Zhao F; Liu N; Zhan P; Jiang X; Liu X
Eur J Med Chem; 2015 Apr; 94():218-28. PubMed ID: 25768704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]